
06/07/2025
We really appreciate the efforts of the Cognition Therapeutics team to make this treatment available to patients through their early access program
"As a physician, it’s always rewarding when you are able to offer a medication to a patient that may make a meaningful impact on their health. To have touched the anonymous donor’s life so meaningfully that they felt compelled to support an expanded access program for so many people is humbling and rewarding."
- Dr. James Galvin, MD, MPH, and Lead EAP Investigator
Learn more about the expanded access program : https://tinyurl.com/28cp3gzt